Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-12-22
pubmed:abstractText
Alveolar osteitis (AO) is characterized by excess fibrinolysis, leading to early dissociation of the clot that normally follows tooth extraction. Nonetheless, scarce information is available on the fibrinolytic system in AO. In this study, we report on the differential composition of postextraction wound healing tissue and of peri-alveolar gingival epithelium from normal healing and AO patients in terms of plasminogen activators, plasminogen activator inhibitor-type 1, and urokinase-type plasminogen activator receptor. Plasminogen activators were studied by overlay zymography, western blotting, and enzyme-linked immunosorbent assay (ELISA). Plasminogen activator inhibitor-type 1 and urokinase receptor were measured by ELISA. In AO, the fibrinolytic activity of wound healing tissue was accounted for by an increase ( approximately 85%) of urokinase-type plasminogen activator, whereas tissue-type plasminogen activator was unchanged. Plasminogen activator inhibitor-type 1 showed a 6.7-fold increase in AO. These results point to key roles of urokinase in AO hyper-fibrinolysis and of plasminogen activator inhibitor type-1 in slowing down the healing response. Peri-alveolar gingival epithelium in AO showed an overall decrease of all the components of the fibrinolytic system, including the urokinase receptor, which indicates a decrease of the migration properties of epithelial cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0909-8836
pubmed:author
pubmed:issnType
Print
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
500-3
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:17184232-Adult, pubmed-meshheading:17184232-Blotting, Western, pubmed-meshheading:17184232-Cell Movement, pubmed-meshheading:17184232-Dry Socket, pubmed-meshheading:17184232-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:17184232-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:17184232-Epithelial Cells, pubmed-meshheading:17184232-Female, pubmed-meshheading:17184232-Fibrinolysis, pubmed-meshheading:17184232-Granulation Tissue, pubmed-meshheading:17184232-Humans, pubmed-meshheading:17184232-Male, pubmed-meshheading:17184232-Plasminogen Activator Inhibitor 1, pubmed-meshheading:17184232-Plasminogen Activators, pubmed-meshheading:17184232-Receptors, Cell Surface, pubmed-meshheading:17184232-Receptors, Urokinase Plasminogen Activator, pubmed-meshheading:17184232-Statistics, Nonparametric, pubmed-meshheading:17184232-Urokinase-Type Plasminogen Activator
pubmed:year
2006
pubmed:articleTitle
Plasminogen activators and inhibitor type-1 in alveolar osteitis.
pubmed:affiliation
Department of Experimental Pathology and Oncology, University of Florence, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't